Teva Challenges UroGen Pharma’s Jelmyto Patent Rights – TipRanks.com – TipRanks
Teva Challenges UroGen Pharma’s Jelmyto Patent Rights – TipRanks.com TipRanks
In: PATENT NEWS
Teva Challenges UroGen Pharma’s Jelmyto Patent Rights – TipRanks.com TipRanks
In: PATENT NEWS
Akebia defends anaemia drug patents at EPO amid huge Fibrogen battle JUVE Patent
In: PATENT NEWS
Case Spotlight: Disclosure dangers – the precarious pre-patent point IAM
In: PATENT NEWS
Tesla still interested in ‘durable glass’ for vehicles, files new patent Repairer Driven News
In: PATENT NEWS
Patent applications from Chinese inventors pass U.S. for first time Axios
In: PATENT NEWS
Lung-Disease Drug Fight Exposes Fault Lines in Patent System Bloomberg Law
In: PATENT NEWS
Avery Dennison Hit With Fees For Dragging Out Patent Suit Law360
In: PATENT NEWS
Palo Alto Seeks Ax Of $151.5M Patent Verdict For Centripetal Law360
In: PATENT NEWS
Medtronic Expands Its Bladder Device Patent Fight Law360
In: PATENT NEWS
In August of 2022, U.S. Senator Thom Tillis (R-NC) released draft legislation titled the Patent Eligibility Restoration Act … Unfortunately, due to a …
Designed by Industrial Action
Copyright © 2024 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION